Chief Medical Officer: Radioligand Background (US)
Summary: This Chief Medical Officer has 5+ years of successful radiotherapy experience including both commercial entry of diagnostics and clinical entry of multiple radioligand trials. Before this he worked on some of the most important immunotherapy drugs in the world, working on B-Cell Lymphoma, Myeloma, Lung Cancer and other oncology trials. He is based on the East Coast, currently open to both new consulting and permanent positions and is a truly respected leader and drug developer.
Experience
Total Years of Industry experience: 25
Total Years of Oncology experience: 14
Years as CMO: 9
Number of INDs entered: 6
Number of registrational trials/successful launches: 2
Achievements: Took over position of CMO for global biotech and steering 3x IND into the clinics and 1x Registrational Trial, bringing company value from $1.1bn to $3.2bn in 2023.
Full Breakdown: Motivations, what he is searching for and an executive summary can be found here.
---
---
